When Is “Low” Too Low? Hematology Abnormalities in the Cancer Patient

Even if you are not the one administering chemotherapy, managing cancer patients requires a keen eye for hematology abnormalities. In this case-based session, Dr. Sue Ettinger will guide you through the essentials of monitoring neutrophils, lymphocytes, and platelets in cancer patients, whether you’re performing a nadir CBC or assessing a patient that is not feeling well posttreatment. Attendees will learn when intervention is necessary versus when careful monitoring is sufficient and will also explore a new hematology technology that can help enhance patient care, giving you the confidence to interpret and act on your hematology results.

Not looking for CE credit for this course? You can skip entering your information below and proceed to viewing the webinar here.